Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TRAF3 and its biological function.

Jeannie Q He1, Gagik Oganesyan, Supriya K Saha

  • 1Department of Microbiology, Immunology and Molecular Genetics, 8University of California, Los Angeles, Los Angeles, California 90095, USA.

Advances in Experimental Medicine and Biology
|July 18, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RNF213 isoform 2 restricts Zika virus through antiviral signaling and viral protein degradation.

iScience·2026
Same author

NF-κB: master regulator of cellular responses in health and disease.

Immunity & inflammation·2026
Same author

Impacts of neutralizing antibody responses on SARS-CoV-2 evolution and its associated disease progression.

Immunity & inflammation·2026
Same author

Cytosolic nucleic acid sensing triggers type I interferon activation via the Hippo kinase LATS1.

The Journal of biological chemistry·2026
Same author

EP300 compromises antitumor immunity by increasing SOCS1 expression.

Journal for immunotherapy of cancer·2025
Same author

Corrigendum to IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice.

The Journal of clinical investigation·2025
Same journal

Mammalian Respiratory Chain Complex Assemblies and Their Links to Mitochondria Stress-Induced Human Diseases.

Advances in experimental medicine and biology·2026
Same journal

Enzyme Assemblies in Nucleotide Metabolism: Structure, Regulation, and Disease Implications.

Advances in experimental medicine and biology·2026
Same journal

The Pyruvate Dehydrogenase Complex: A 90-Year-Old Enigma Shaping the Future of Structural Enzymology.

Advances in experimental medicine and biology·2026
Same journal

Regulation of the Anti-termination RNA Transcription Complex by Lon-Mediated Lambda N Degradation.

Advances in experimental medicine and biology·2026
Same journal

PCNA Macromolecular Complexes: PCNA Serves as a Molecular Hub Regulating Multiple Cellular Processes Inside and Outside of the Nucleus.

Advances in experimental medicine and biology·2026
Same journal

Dynamic Assemblies in Genome Maintenance.

Advances in experimental medicine and biology·2026
See all related articles

Tumor necrosis factor receptor associated factor 3 (TRAF3) is a key regulator of immune responses. It negatively controls NF-kappaB signaling and positively influences type I IFN production, impacting both innate and adaptive immunity.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Tumor necrosis factor receptor associated factor 3 (TRAF3) is a member of the TRAF family, sharing structural similarities with other TRAFs.
  • TRAF3's function has been challenging to study due to its lack of induction of common TRAF-inducible pathways (NF-kappaB, JNK) and early lethality in knockout mice.

Purpose of the Study:

  • To elucidate the distinct biological functions of TRAF3.
  • To understand TRAF3's role in regulating immune responses.

Main Methods:

  • The abstract does not specify the methods used.
  • Further research is needed to detail the experimental approaches.

Main Results:

  • TRAF3 acts as a negative regulator of the Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) pathway.

Related Experiment Videos

  • TRAF3 functions as a positive regulator of type I Interferon (IFN) production.

    • Conclusions:

    • TRAF3 is a critical regulator of both innate and adaptive immune responses.
    • TRAF3 plays dual roles in immune signaling, impacting NF-kappaB and type I IFN pathways.